Akari Therapeutics focusing on developing precision ADCs for cancer treatment, seeking non-dilutive capital.
From GlobeNewswire: 2025-04-16 08:00:00 Akari Therapeutics is making strides in developing next-generation precision Antibody Drug Conjugates (ADCs) for multiple cancer